Please login to the form below

Not currently logged in
Email:
Password:

Deal Watch July 2016

Medius Deal Watch

Real deals, real money and - for some - reality bites

Why multichannel is not an in/out option

When it comes to multichannel communications, pharma cannot afford to maintain the status quo

Managing value: Why early asset development and commercialisation are important

Realising the full value of your asset - clinically and commercially - means thinking beyond the pure scientific value, even at the very early stages of development

Allergies and asthma

Reframing the conversation from disease burden to prevention and health promotion

From two final medical signatories to one

Is the UK pharma industry ready for this switch?

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – it's free to add your pharma/healthcare campaigns. Just contact us.

Webinars

Strengthening market access deliverables by harnessing the patient journey

In today’s multi-stakeholder environment, pharma companies need to coordinate their stakeholder interactions between functions to ensure consistency of message and efficiency of cost.

The value of early asset development and commercialisation

Linking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets

Developing medical education that advances patient outcomes

As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in

Customer engagement design in pharma

In recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Video

Webinar: Customer engagement design

Customer engagement design pharma Webinar: Customer engagement design

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

A stumble, but not a fall – what’s next for Opdivo?

Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.

Blog: A new 'At your service' model for pharma

Turning the traditional sales model on its head to deliver commercial outcomes without selling at all

Meet Anthill at conferences in London

October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit

Immuno-oncology; bringing patients closer to treatment

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Helen Lawn and Associates

Established in 2000, Helen Lawn and Associates has gained widespread industry recognition as a trusted, UK-based healthcare PR agency. Our...

Infographics